Cassava Sciences Inc (NASDAQ: SAVA), a Austin, Texas, company, gained to close at $84.86 Tuesday after gaining $4.88 (6.10%) on volume of 10,309,499 shares. The stock ranged from a high of $93.63 to a low of $82.09 while Cassava’s market cap now stands at $3,395,134,378.
About Cassava Sciences Inc
Cassava Sciences’ mission is to discover and develop innovations for chronic, neurodegenerative conditions. Over the past 10 years, Cassava Sciences has combined state-of-the-art technology with new insights in neurobiology to develop novel solutions for Alzheimer’s disease.